Understanding interleukin 11 as a disease gene and therapeutic target
Biochemical Journal · 13.12.2023 · 480 (23) · 1987-2008
DOI: 10.1042/bcj20220160 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Journal, online erschienen am 06.12.2023. Verfasst von Stuart A Cook. Beteiligte Einrichtung: MRC-London Institute of Medical Sciences, Hammersmith Hospital Campus, London, U.K. Hauptthemen laut MEDLINE: Endothelial Cells, Interleukin-11. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Interleukin 11 (IL11) is an elusive member of the IL6 family of cytokines. While initially thought to be a haematopoietic and cytoprotective factor, more recent data show instead that IL11 is redundant for haematopoiesis and toxic. In this review, the reasons that led to the original misunderstandings of IL11 biology, which are now understandable, are explained with particular attention on the use of recombinant human IL11 in mice and humans. Following tissue injury, as part of an evolutionary ancient homeostatic response, IL11 is secreted from damaged mammalian cells to signal via JAK/STAT3, ERK/P90RSK, LKB1/mTOR and GSK3β/SNAI1 in autocrine and paracrine. This activates a program of mesenchymal transition of epithelial, stromal, and endothelial cells to cause inflammation, fibrosis, and stalled endogenous tissue repair, leading to organ failure. The role of IL11 signalling in cell- and organ-specific pathobiology is described, the large unknowns about IL11 biology are discussed and the promise of targeting IL11 signalling as a therapeutic approach is reviewed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MRC-London Institute of Medical Sciences, Hammersmith Hospital Campus, London, U.K.
- National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore.
- Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.
ORCID-Profile: Stuart A Cook
Förderung
- Medical Research Council
Zitieren
APA
Cook, S. A. (2023). Understanding interleukin 11 as a disease gene and therapeutic target. Biochemical Journal, 480(23), 1987-2008. https://doi.org/10.1042/bcj20220160
Vancouver
Cook SA. Understanding interleukin 11 as a disease gene and therapeutic target. Biochemical Journal. 2023;480(23):1987-2008. doi:10.1042/bcj20220160
BibTeX
@article{Cook2023,
author = {Cook, Stuart A},
title = {Understanding interleukin 11 as a disease gene and therapeutic target},
journal = {Biochemical Journal},
year = {2023},
volume = {480},
number = {23},
pages = {1987--2008},
doi = {10.1042/bcj20220160}
}
EUVIMED